IScibe and Johnson & Johnson Announce Joint-Market Deal

Article

(SAN MATEO, Calif.)IScribe, Inc., a provider of electronic, hand-held prescription-writing systems for doctors, is expected to announce a joint-market deal with pharmaceutical giant Johnson & Johnson. The Johnson & Johnson sales force will promote iScribe to primary-care doctors and specialists. In exchange, Johnson & Johnson will obtain the right to sponsor advertising and health information on the system. This will include Johnson & Johnson paying a sponsorship fee that will be determined by the number of physicians using the iScribe system. For more information visit www.iscribe.com.

Recent Videos
Anthony Bondon CRCST, CHL, BSM, AAS, SME, LSSYB
Deannard Esnard, CRCST, CIS, CER, CHL, CFER, CQUIA
Kevin Bush, Jr, DHSc, EdD, MSHA, MA, MS, FACHE
Vatsala Rangachar Srinivasa, MPH
Sarah Vinson, MBA, CRCST
Kevin Anderson, MBA, BS, CRCST, Senior Manager, Commercial Education Services, Heatlthmark, a Getinge Company
Damien Berg, BA, BS, CRCST, AAMIF, is the vice president of strategic initiatives for the HSPA.
Annet Adegboyega, DNP, MSN, BSN, RN, CNOR; Mihyun "Rose" Jang, MSN, MPH, BSN, RN, CNOR; and Renilda Tijones, MSN, BSN, RN, CNOR.
Roundtable of Vet IPs (Adobe Stock)
APIC 2025 President Carol McLay, DrPH, MPH, RN, CIC FAPIC   (Image credit: APIC)
Related Content